Myeloma Minute: New MRD Testing Launched

MyelomaMinute
October 13, 2016​


New MRD Testing Launched at 2nd IMF-EuroFlow Workshop

After years of dedicated research, a state-of-the-art myeloma test developed with the support of the IMF Black Swan Research Initiative® is on the brink of widespread availability. IMF Chairman Dr. Brian Durie reports from Spain, where an international workshop offered hands-on training and the latest news about this exciting new technology. To read Dr. Durie’s blog, click HERE.

FDA Grants Priority Review for Daratumumab in Relapsed Multiple Myeloma

On October 7, 2016, the FDA granted Priority Review to the supplemental Biologics License Application for the use of daratumumab in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy. Priority Review is an FDA designation for drugs that treat a serious condition and may provide a significant improvement in safety or efficacy. Learn more HERE.

IMF Comedy Celebration Showcases a Celebrity Cast and Stellar Auction Items

Tickets are on sale now for the 10th Annual Comedy Celebration hosted by Ray Romano and featuring a cast of celebrity comedians and live music. In honor of the 10th year of this event, we’ve received some stellar items for the silent auction, including: House seats to see Hamilton at the Pantages Theatre in Los Angeles, an autographed electric guitar signed by legendary musician Joe Walsh WITH a Skype lesson from the man himself, a tour of the NBC Nightly News studio with host Lester Holt, as well as fine jewelry, sports memorabilia, and trips! 

Pre-register for FREE for the Next "Living Well with Myeloma" Teleconference: Pre-ASH Highlights

Join Dr. Brian G.M. Durie as he moderates “Pre-ASH – What Patients & Caregivers Can Look Forward To,” a teleconference on Thursday, November 17, 2016 at 4:00 p.m. PT / 7:00 p.m. ET. Dr. Durie will focus on issues in the myeloma community that are relevant to this year’s American Society of Hematology (ASH) Conference, which convenes in San Diego on December 2–5, 2016. 

Second Annual Walk-a-Thon to End Myeloma  

Six years ago, Theresa Tucker was diagnosed with multiple myeloma. With the help of her medical and support teams, she gained knowledge about the illness and underwent treatment. Today, to raise money for the International Myeloma Foundation, she organized the Second Annual Walk-a-Thon to End Multiple Myeloma in Flushing Meadows Park, which will take place in Queens, New York on Sunday, October 16, 2016 from 8:00 a.m. ET to 11:00 a.m. ET. This event does not require pre-registration. Just arrive shortly before 8:00 a.m. to sign-up and walk! Learn more HERE.


We Would Like to Thank Our Sponsors: Takeda, Celgene, Amgen, and Bristol-Myers Squibb

Subscribe to the Myeloma Minute

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.